Eupafolin suppresses prostate cancer by targeting phosphatidylinositol 3‐kinase‐mediated Akt signaling

Publisher： John Wiley & Sons Inc

E-ISSN： 1098-2744|54|9|751-760

ISSN： 0899-1987

Source： Molecular Carcinogenesis, Vol.54, Iss.9, 2015-09, pp. : 751-760

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hirsutenone in Alnus extract inhibits akt activity and suppresses prostate cancer cell proliferation

By  

Molecular Carcinogenesis, Vol. 54, Iss. 11, 2015-11 ,pp. : 1354-1362

John Wiley & Sons Inc

Access to resources Recommend Favorite

Apigenin suppresses insulin‐like growth factor I receptor signaling in human prostate cancer: An in vitro and in vivo study

By  

Molecular Carcinogenesis, Vol. 48, Iss. 3, 2009-03 ,pp. : 243-252

John Wiley & Sons Inc

Access to resources Recommend Favorite

The PI3K/AKT signaling pathway: Associations of miRNAs with dysregulated gene expression in colorectal cancer

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 243-261

John Wiley & Sons Inc

Access to resources Recommend Favorite

Silibinin prevents prostate cancer cell‐mediated differentiation of naïve fibroblasts into cancer‐associated fibroblast phenotype by targeting TGF β2

By  

Molecular Carcinogenesis, Vol. 54, Iss. 9, 2015-09 ,pp. : 730-741

John Wiley & Sons Inc

Access to resources Recommend Favorite

Upregulation of UBE2Q1 via gene copy number gain in hepatocellular carcinoma promotes cancer progression through β‐catenin‐EGFR‐PI3K‐Akt‐mTOR signaling pathway

By  

Molecular Carcinogenesis, Vol. 57, Iss. 2, 2018-02 ,pp. : 201-215

John Wiley & Sons Inc

Access to resources Recommend Favorite